MENU
LGND
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Ligand Pharmaceuticals (LGND) Ownership - Who owns Ligand Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.83B
P/E Ratio
42.96
Total Cash
226.93M
Projected Growth
N/A
Total Debt
7.58M
Revenue
133.48M
Risk (Beta)
1.04
Dividend Yield
N/A
Total Cash/Share
12.42
Total Debt/Equity
8.88
Revenue/Share
7.43 USD as % of share price
Fundamentals
LGND
Capitalization
1.83B
P/E Ratio
42.96
Risk (Beta)
1.04
Dividend Yield
N/A
Total Cash
227M
Total Cash/Share
12.42
Total Debt
7.58M
Total Debt/Equity
8.88
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.43%
Revenue
133M
ROE
N/A
Book Value
775M
P/B Ratio
2.36
Cash Flow
N/A
Earnings
2.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
19K
Current Ratio
16.82
Current Revenue Per Employee
716051.75
Dividends Per Share - Security
N/A
EBITDA
88.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
93.00
Revenue To Assets
5.19
Shares Held By Institutions
3.05B
Shares Outstanding - Current
18.3M
Total Liabilities
91.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
50.042
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com